Press Releases


2017 | 2016 | 2015 | 2014
E-mail Alerts Receive E-mail Alerts | RSS RSS Feeds
Keyword Search
 
DateTitle 
11/15/17Illumina Grows Clinical IVD Portfolio with Introduction of NextSeq™ 550Dx System and Expanded Use of MiSeq™Dx SystemPrinter Friendly Version
11/08/17Illumina Names Gary S. Guthart, Ph.D., to its Board of Directors, Adding Decades of Leadership Experience in HealthcarePrinter Friendly Version
10/24/17Illumina Reports Financial Results for Third Quarter of Fiscal Year 2017Printer Friendly Version
10/16/17Illumina Releases NovaSeq S4 Flow Cell and NovaSeq Xp WorkflowPrinter Friendly Version
10/10/17Illumina to Announce Third Quarter 2017 Financial Results on Tuesday, October 24, 2017Printer Friendly Version
09/07/17Illumina Files New Patent Infringement Suit Against Premaitha Health plcPrinter Friendly Version
08/24/17Illumina and Telegraph Hill Partners Launch Verogen, Inc. to Drive Adoption of Next-Generation Sequencing in the Global Forensic Genomics MarketPrinter Friendly Version
08/01/17Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017Printer Friendly Version
07/11/17Illumina to Announce Second Quarter 2017 Financial Results on Tuesday, August 1, 2017Printer Friendly Version
06/29/17Illumina Announces FDA-approved Next-Generation Sequencing Cancer Companion Diagnostic Test KitPrinter Friendly Version
06/26/17Genomics England Adopts Illumina’s BaseSpace Variant Interpreter for CancerPrinter Friendly Version
05/30/17Illumina to Webcast Live Presentation at the Goldman Sachs Global Healthcare ConferencePrinter Friendly Version
05/22/17Illumina Names Mark Van Oene Chief Commercial Officer, Sales Leader Brings Genomics Expertise and Strong Commercial Leadership Experience to the RolePrinter Friendly Version
05/04/17Illumina to Webcast Live Presentation at the Bank of America Merrill Lynch Health Care ConferencePrinter Friendly Version
04/25/17Illumina Reports Financial Results for First Quarter of Fiscal Year 2017Printer Friendly Version
04/11/17Illumina to Announce First Quarter 2017 Financial Results on Tuesday, April 25, 2017Printer Friendly Version
04/10/17Illumina Launches the VeriSeq™ NIPT Solution in EuropePrinter Friendly Version
04/03/17Illumina Advances the Use of Genomics in Precision Oncology, Donates Thousands of Somatic Interpretations to CIViCPrinter Friendly Version
02/28/17Illumina Announces the iHope Network, an Expansion of Its iHope Philanthropic Clinical Whole Genome Sequencing ProgramPrinter Friendly Version
02/21/17Illumina to Webcast Live Presentation at the Cowen and Company Annual Health Care ConferencePrinter Friendly Version
02/20/17Illumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to IlluminaPrinter Friendly Version
01/31/17Illumina Reports Full Financial Results for Fourth Quarter and Fiscal Year 2016Printer Friendly Version
01/30/17Illumina Debuts VeriSeq™ Analysis Software (48 Samples), Optimized Data Analysis for Noninvasive Prenatal TestingPrinter Friendly Version
01/27/17Illumina Names Caroline Dorsa to Its Board of Directors, Adding Over 30 Years of Leadership Experience in the Healthcare, Telecommunications and Energy IndustriesPrinter Friendly Version
01/17/17Illumina to Announce Fourth Quarter and Fiscal Year 2016 Financial Results on Tuesday, January 31, 2017Printer Friendly Version
01/12/17Illumina, NRGene Collaborate to Accelerate Development of New Molecular Breeding Tools for Cattle to Support Global Food ProductionPrinter Friendly Version
01/09/17Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex DiseasesPrinter Friendly Version
01/09/17Illumina Introduces the NovaSeq Series—a New Architecture Designed to Usher in the $100 GenomePrinter Friendly Version
01/09/17Philips and Illumina join forces to offer integrated genomics solutions for oncologyPrinter Friendly Version
01/09/17IBM and Illumina Partner to Standardize Genomic Data InterpretationPrinter Friendly Version
01/05/17GRAIL Plans to Raise in Excess of $1B in Series B FundingPrinter Friendly Version
01/03/17Illumina Taps Garret Hampton, One of the World’s Leading Clinical Genomics Experts, to Head its Clinical Genomics UnitPrinter Friendly Version